Viromed Medical AG (ETR:VME)

Market Cap	99.88M +40.9%
Revenue (ttm)	5.22M +115.7%
Net Income	342.08K
EPS	n/a
Shares Out	21.25M
PE Ratio	291.97
Forward PE	31.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,404
Open	4.640
Previous Close	4.700
Day's Range	4.620 - 4.920
52-Week Range	2.600 - 8.450
Beta	1.67
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 29, 2026

About Viromed Medical AG

Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally. The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections. It also provides non-prescription health products in the cosmetics, nutritional supplement, and medical and nursing supplies. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was founded in 2021 and is based in Rellingen, Germany.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 17
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: VME

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error